Press release
2025 Preeclampsia Drugs Industry Trends Report: Long-Term Outlook Through 2034
Preeclampsia Drugs
How Large Will the Preeclampsia Drugs Market Size By 2025?
The market size for drugs treating preeclampsia has seen robust growth in recent years. The market is expected to expand from $1.25 billion in 2024 to $1.37 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. The upswing during the historic period has been driven by enhanced awareness regarding maternal health, investment in research and development, concerns regarding neonatal health, and improvements in early detection.
How Big Is the Preeclampsia Drugs Market Size Expected to Grow by 2029?
In the upcoming years, the preeclampsia drugs market is projected to experience a swift expansion. This market is forecasted to reach "$2.1 billion in 2029 with a compound annual growth rate (CAGR) of 11.2%. The market expansion during the predictive period can be credited to factors such as personalized medicine, non-invasive diagnostic instruments, targeted treatments, and health equality initiatives. The primary trends anticipated during this period consist of preventative methodologies, patient-focused care, constant observation, and regulatory concentration.
View the full report here:
https://www.thebusinessresearchcompany.com/report/preeclampsia-drugs-global-market-report
Which Key Market Drivers Powering Preeclampsia Drugs Market Expansion and Growth?
There's an anticipated surge in the preeclampsia drug market due to the prevalence of diabetes among pregnant women. Diabetes, a long-term metabolic disorder, results in elevated blood glucose levels. Preeclampsia, a detrimental condition during pregnancy, is associated with high blood pressure and organ injuries. Metformin, a drug used to treat preeclampsia, is commonly prescribed to pregnant women diagnosed with early preeclampsia. As per the data from the National Library of Medicine, a US-based biomedical library and biomedical informatics center, in December 2022, the number of gestational diabetes mellitus (GDM) cases recorded was 20,865, marking a 6.56% increase compared to the previous year. We can thus, anticipate that the escalating rate of diabetes among pregnant women will push the preeclampsia drug market forward.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13025&type=smp
What Trends Will Shape the Preeclampsia Drugs Market Through 2029 and Beyond?
Leading enterprises in the preeclampsia medicine industry are keen on inventing sophisticated drug therapies to enhance their place in the market. To illustrate, Comanche Biopharma Corp., an American biopharmaceutical company, announced in March 2023 that its novel siRNA treatment, CBP-4888, has received Food and Drug Administration (FDA) approval for an investigational new drug (IND) application for treating preeclampsia. Administered subcutaneously, CBP-4888 is an siRNA therapy that curtails the production of soluble fms-like tyrosine kinase-1 (sFLT1) in the placenta. Overproduction of the sFLT1 protein by the placenta, which then enters the mother's bloodstream, is primarily responsible for preeclampsia. CBP-4888 is capable of mitigating preeclampsia symptoms, such as elevated blood pressure and harm to organs, potentially facilitating a safe prolongation of pregnancy.
What Are the Emerging Segments in the Preeclampsia Drugs Market?
The preeclampsia drugs market covered in this report is segmented -
1) By Type: Mild Preeclampsia, Severe Preeclampsia
2) By Treatment: Medication to Lower Hypertension (B.P), Corticosteroids, Anticonvulsants Medication
3) By Route of Administration: Oral, Parenteral, Other Route of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Other Distribution Channels
5) By End-User: Hospitals, Specialty Clinics, Diagnostic Centers, Other End-Users
Subsegments:
1) By Mild Preeclampsia: Blood Pressure Management, Proteinuria Monitoring, Lifestyle Modifications
2) By Severe Preeclampsia: Antihypertensive Medications, Magnesium Sulfate Therapy, Emergency Delivery Management
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13025&type=smp
Who Are the Global Leaders in the Preeclampsia Drugs Market?
Major companies operating in the preeclampsia drugs market are AbbVie Inc., Pfizer Inc., Johnson & Johnson Co, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi S.A., Celgene Corp, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceuticals Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Siemens Healthcare GmbH, Boehringer Ingelheim Group, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Union Chimique Belge SA, Otsuka Pharmaceutical Co. Ltd., Kyowa Kirin Co Ltd., Mallinckrodt Pharmaceuticals Limited, Comanche Biopharma Corp, Genentech Inc., Diabetomics Inc.
Which are the Top Profitable Regional Markets for the Preeclampsia Drugs Industry?
North America was the largest region in the preeclampsia drugs market in 2024. The regions covered in preeclampsia drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13025
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2025 Preeclampsia Drugs Industry Trends Report: Long-Term Outlook Through 2034 here
News-ID: 4183295 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Preeclampsia
European Preeclampsia Market Outlook 2025-2035 Key Developments & Future Scope
The European preeclampsia market is set for robust expansion over the 2025-2035 decade, underpinned by rising maternal-health screening, growing adoption of biomarker diagnostics, and increasing commitment to early detection. As healthcare systems across the region strive to reduce pregnancy-related complications, preeclampsia diagnostics are emerging as a central component of prenatal care.
Market Size & Forecast
The global preeclampsia market is projected to expand from approximately USD 1.36 billion in 2025 to around…
Emerging Preeclampsia Drugs Market Trends: Leading Companies In The Preeclampsia …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Preeclampsia Drugs Market Size Growth Forecast: What to Expect by 2025?
The market size for drugs used in the treatment of preeclampsia has seen a swift escalation in the recent past. This market is projected to soar from a value of $1.25 billion in 2024 to $1.38 billion in…
Preeclampsia Diagnostics Market | Exploring Current Trends and Growth Status for …
Preeclampsia Diagnostics Market size was valued at USD 1.2 Billion in 2022 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 9.5% from 2024 to 2030.
Preeclampsia Diagnostics Market Outlook and Investment Analysis
What is the current market outlook for Preeclampsia Diagnostics?
The Preeclampsia Diagnostics Market is experiencing growth due to increasing awareness, advancements in diagnostic technologies, and the rising prevalence of preeclampsia globally. Growing demand for…
Preeclampsia Diagnostics Market Forecast Report 2032
Preeclampsia Diagnostics Market By Test Type (Blood Test, Urine Test, Others), By Product & Services (Instruments, Reagents & Consumables, Services), By End-User (Hospitals, Diagnostic Centers, Others) - Growth, Share, Opportunities & Competitive Analysis, 2024 - 2032
The preeclampsia diagnostics market [https://www.acutemarketreports.com/report/preeclampsia-diagnostics-market] is expected to grow at a CAGR of 4.1% during the forecast period of 2024 to 2032. This growth will be driven by developments in the discovery of biomarkers, the…
Preeclampsia Market Size, Share, Trends, Report and Forecast 2024-2032
The preeclampsia market size is anticipated to grow at a CAGR of 1.8% during the forecast period of 2024-2032, driven by advancements in early detection and monitoring along with growing hypertension prevalence across major markets.
Preeclampsia: Introduction
Preeclampsia is a pregnancy complication characterized by high blood pressure and signs of damage to organ systems, often the kidneys. It usually occurs after 20 weeks of pregnancy in women whose blood pressure had been…
Preeclampsia Diagnostics Market - Empowering Maternal Health: Preeclampsia Diagn …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Preeclampsia Diagnostics Market.
Preeclampsia Diagnostics Market: https://www.growthplusreports.com/report/preeclampsia-diagnostics-market/9109
The Preeclampsia Diagnostics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
